Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.33 |
| ▸ | PARP1 | P09874 | 2/20 | 0.33 |
| ▸ | PARP2 | Q9UGN5 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | PNMT | P11086 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2985296 | 0.86 | PARP1 (0.33) | PARP1PARP2KCNH2PNMT | |
| SCHEMBL5149183 | 0.84 | ALDH1A1 (0.32) | ALOX15ALDH1A1LMNASMN1; SMN2HTT | |
| SCHEMBL5179917 | 0.81 | ALDH1A1 (0.40) | ALDH1A1LMNASMN1; SMN2HTTMAPT | |
| SCHEMBL5147297 | 0.80 | ALDH1A1 (0.34) | ALOX15ALDH1A1LMNASMN1; SMN2HTT | |
| SCHEMBL5147462 | 0.79 | ALDH1A1 (0.42) | ALDH1A1LMNASMN1; SMN2HTTMAPT | |
| SCHEMBL5147380 | 0.79 | ALDH1A1 (0.40) | ALDH1A1LMNASMN1; SMN2HTTMAPT | |
| SCHEMBL5147364 | 0.78 | ALDH1A1 (0.34) | ALOX15ALDH1A1LMNASMN1; SMN2HTT | |
| SCHEMBL5146079 | 0.77 | ALDH1A1 (0.38) | ALDH1A1LMNASMN1; SMN2HTTMAPT | |
| SCHEMBL5147360 | 0.77 | CYP2A6 (0.35) | ALDH1A1SMN1; SMN2HTTMAPTNPC1 | |
| SCHEMBL5145889 | 0.77 | ALDH1A1 (0.35) | ALOX15ALDH1A1LMNASMN1; SMN2HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1831207-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | Amgen Inc. (US) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006066172-A1 | AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE | AMGEN, INC. (US) | 2006-06-22 | — | — | WO | disclosed |